Page 1 | Search Results | Blood | American Society of Hematology

1-14 of 14

Sort by

Sort Order Select

Journal Articles

The Balance of Effector and Regulatory Cell Populations in Oral Chronic GVHD: Potential Role of IL-15.

Matin Imanguli, DDS, Frances Hakim, PhD, William Swaim, PhD, Jean-Pierre Guadagnini, DDS, Stacy League, BA, Ronald Gress, MD, Steven Pavletic, MD

Blood (2007) 110 (11): 1059.

https://doi.org/10.1182/blood.V110.11.1059.1059

Published: 2007

Journal Articles

Safety and Efficacy of Cytotoxic Chemotherapy after Allogeneic Hematopoietic Stem Cell Transplantation for Relapsed Hematologic Malignancy.

Nancy M. Hardy, MD, Jeanne Odom, RN, Kelly Snow, RN, Robert Dean, MD, Steven Pavletic, MD, Claude Sportes, MD, Ronald Gress, MD, Daniel H. Fowler, MD, Michael R. Bishop, MD

Blood (2006) 108 (11): 5333.

https://doi.org/10.1182/blood.V108.11.5333.5333

Published: 2006

Journal Articles

Ex-Vivo Reduction of Allograft T Cell Dose Does Not Prevent Acute Graft-vs-Host Disease after Reduced-Intensity Hematopoietic Stem Cell Transplantation.

Nancy M. Hardy, MD, Frances Hakim, PhD, Seth Steinberg, PhD, Michael Krumlauf, Rebecca Babb, Jeanne Odom, Daniel Fowler, MD, Ronald Gress, MD, Michael R. Bishop, MD

Blood (2006) 108 (11): 2871.

https://doi.org/10.1182/blood.V108.11.2871.2871

Published: 2006

Journal Articles

Phase II Clinical Experience with Dose-Adjusted EPOCH-Fludarabine, a Novel Regimen for Targeted Immune Depletion (TID) and Disease Control in Patients with Lymphoid Malignancies Prior to Reduced-Intensity Allogeneic Hematopoietic Stem Cell Transplantation (RIST).

Robert M. Dean, MD, Daniel Fowler, MD, Wyndham H. Wilson, MD, PhD, Frances Hakim, PhD, Seth Steinberg, PhD, Jeanne Odom, RN, Catherine Chow, MD, Claude Sportes, MD, Juan Gea-Banacloche, MD, Steven Z. Pavletic, MD, Nancy M. Hardy, MD, Ronald Gress, MD, Michael R. Bishop

Blood (2006) 108 (11): 317.

https://doi.org/10.1182/blood.V108.11.317.317

Published: 2006

Journal Articles

Early Recovery of Thymus-Derived Naïve T Cells in Pediatric Patients (pts) Treated with Non-Myeloablative Allogeneic Peripheral Blood Stem Cell Transplantation (NMSCT) for Cancer.

Terry J. Fry, MD, Alison R. Rager, Frances Hakim, PhD, Cynthia Love, Paula Layton, Daniel Fowler, MD, Michael R. Bishop, MD, Ronald Gress, MD, Crystal L. Mackall, MD, Alan S. Wayne, MD

Blood (2006) 108 (11): 310.

https://doi.org/10.1182/blood.V108.11.310.310

Published: 2006

Journal Articles

IL7 Administration in Humans Results in Preferential Expansion of Naive and Memory CD4+ & CD8+ T Cells with a Relative Decrease in Regulatory T-Cells (T-Regs).

Claude Sportes, MD, Michael Krumlauf, RN, Rebecca Babb, RN, Ladan Foruraghi, RN, Janine Daub, RN, Daniele Avila, RN, Catherine Chow, MD, Hua Zhang, PhD, Kevin Chua, PhD, Terry Fry, MD, Sarfraz Memon, PhD, Frances Hakim, PhD, Thomas Fleisher, MD, Margaret Brown, BSN, Julie Engel, PhD, Renaud Buffet, MD, Michel Morre, DVM, Ronald Gress, MD, Crystal Mackall, MD

Blood (2006) 108 (11): 871.

https://doi.org/10.1182/blood.V108.11.871.871

Published: 2006

Journal Articles

Non-Myeloablative Allogeneic Hematopoietic Stem Cell Transplantation (SCT) with Pre-Transplant Targeted Immune Depletion Results in Rapid Full Donor Engraftment in Pediatric Patients with Malignancy.

Terry J. Fry, MD, Teresa Cardesa-Salzman, MD, Frances Hakim, PhD, Cynthia Love, R.N., BSN., Paula Layton, R.N., BSN, Ronald Gress, MD, Daniel Fowler, MD, Michael R. Bishop, MD, Crystal L. Mackall, MD, Alan S. Wayne, MD

Blood (2005) 106 (11): 3672.

https://doi.org/10.1182/blood.V106.11.3672.3672

Published: 2005

Journal Articles

A Vaccination Regimen Incorporating the Synergistic Combination of CpG-Containing Oligodeoxynucleotides and IL-2 Can Elicit CD8+ T Cell Responses That Effect Anti-Tumor Immunity from T Cell Repertoires Undergoing Reconstitution by Homeostatic Peripheral Expansion after BMT.

James Kochenderfer, Christopher Chien, Jessica Simpson, Ronald Gress

Blood (2005) 106 (11): 61.

https://doi.org/10.1182/blood.V106.11.61.61

Published: 2005

Journal Articles

Pilot Clinical Trial of Adoptive Immunotherapy with Chimeric, Co-Stimulated Tumor-Infiltrating Lymphocytes after Allogeneic Hematopoietic Stem Cell Transplantation.

Nancy M. Hardy, MD, Vicki Fellowes, Jacopo Mariotti, MD, Charles Carter, Carl June4, MD, Bruce L. Levine4, PhD, Frances Hakim, PhD, Robert Vonderheide4, MD, DPhil, Ronald Gress, MD, Elizabeth J. Read, MD, Daniel Fowler, MD, Michael R. Bishop, MD

Blood (2005) 106 (11): 5407.

https://doi.org/10.1182/blood.V106.11.5407.5407

Published: 2005

Journal Articles

B-cell recovery following rituximab-based therapy is associated with perturbations in stromal derived factor-1 and granulocyte homeostasis

Kieron Dunleavy, Frances Hakim, Hyun Kyung Kim, John E. Janik, Nicole Grant, Takayuki Nakayama, Therese White, George Wright, Larry Kwak, Ronald Gress, Giovanna Tosato, Wyndham H. Wilson

Blood (2005) 106 (3): 795–802.

https://doi.org/10.1182/blood-2004-08-3198

Published: 2005

Journal Articles

Preliminary Results of Sibling Donor Immunization with Patient-Derived Id-KLH Vaccine Prior to Reduced-Intensity Allogeneic Stem Cell Transplantation for Multiple Myeloma.

Michael R. Bishop, MD, Sattva Neelapu, MD, Daniel H. Fowler, Michael Krumlauf, RN, Ronald Gress, MD, Larry W. Kwak, MD, PhD

Blood (2004) 104 (11): 814.

https://doi.org/10.1182/blood.V104.11.814.814

Published: 2004

Journal Articles

Insulin-Like Growth Factor I Is a Positive Regulator of Thymic Function.

Yu-Waye Chu, M.D., Shoshana Yakar, Ph.D., Derek LeRoith, Ph.D., Ronald Gress, M.D.

Blood (2004) 104 (11): 732.

https://doi.org/10.1182/blood.V104.11.732.732

Published: 2004

Journal Articles

Synergism between CpG ODN and IL-2 Leads to Massive CD8 + T Cell Responses Against a Self-Antigen and Epitope-Specific Anti-Tumor Immunity.

Jim Kochenderfer, MD, Chris Chien, BS, Ronald Gress, MD

Blood (2004) 104 (11): 3239.

https://doi.org/10.1182/blood.V104.11.3239.3239

Published: 2004

Journal Articles

Immunotherapy and Chemotherapy Can Result in Long-Term Survival for Patients with Recurrent or Progressive Non-Hodgkin’s Lymphoma after Reduced-Intensity Allogeneic Stem Cell Transplantation.

Michael R. Bishop, MD, Robert M. Dean, MD, Wyndham H. Wilson, MD, PhD, Jeanne Odom, RN, Seth Steinberg, PhD, Michael Krumlauf, RN, Claude Kasten-Sportes, MD, Steven Z. Pavletic, MD, Kathleen Castro, RN, Tracey Chinn, RN, Ronald Gress, MD, Daniel H. Fowler, MD

Blood (2004) 104 (11): 1643.

https://doi.org/10.1182/blood.V104.11.1643.1643

Published: 2004

NARROW

The Balance of Effector and Regulatory Cell Populations in Oral Chronic GVHD: Potential Role of IL-15.

Safety and Efficacy of Cytotoxic Chemotherapy after Allogeneic Hematopoietic Stem Cell Transplantation for Relapsed Hematologic Malignancy.

Ex-Vivo Reduction of Allograft T Cell Dose Does Not Prevent Acute Graft-vs-Host Disease after Reduced-Intensity Hematopoietic Stem Cell Transplantation.

Phase II Clinical Experience with Dose-Adjusted EPOCH-Fludarabine, a Novel Regimen for Targeted Immune Depletion (TID) and Disease Control in Patients with Lymphoid Malignancies Prior to Reduced-Intensity Allogeneic Hematopoietic Stem Cell Transplantation (RIST).

Early Recovery of Thymus-Derived Naïve T Cells in Pediatric Patients (pts) Treated with Non-Myeloablative Allogeneic Peripheral Blood Stem Cell Transplantation (NMSCT) for Cancer.

IL7 Administration in Humans Results in Preferential Expansion of Naive and Memory CD4+ & CD8+ T Cells with a Relative Decrease in Regulatory T-Cells (T-Regs).

Non-Myeloablative Allogeneic Hematopoietic Stem Cell Transplantation (SCT) with Pre-Transplant Targeted Immune Depletion Results in Rapid Full Donor Engraftment in Pediatric Patients with Malignancy.

A Vaccination Regimen Incorporating the Synergistic Combination of CpG-Containing Oligodeoxynucleotides and IL-2 Can Elicit CD8+ T Cell Responses That Effect Anti-Tumor Immunity from T Cell Repertoires Undergoing Reconstitution by Homeostatic Peripheral Expansion after BMT.

Pilot Clinical Trial of Adoptive Immunotherapy with Chimeric, Co-Stimulated Tumor-Infiltrating Lymphocytes after Allogeneic Hematopoietic Stem Cell Transplantation.

B-cell recovery following rituximab-based therapy is associated with perturbations in stromal derived factor-1 and granulocyte homeostasis

Preliminary Results of Sibling Donor Immunization with Patient-Derived Id-KLH Vaccine Prior to Reduced-Intensity Allogeneic Stem Cell Transplantation for Multiple Myeloma.

Insulin-Like Growth Factor I Is a Positive Regulator of Thymic Function.

Synergism between CpG ODN and IL-2 Leads to Massive CD8 + T Cell Responses Against a Self-Antigen and Epitope-Specific Anti-Tumor Immunity.

Immunotherapy and Chemotherapy Can Result in Long-Term Survival for Patients with Recurrent or Progressive Non-Hodgkin’s Lymphoma after Reduced-Intensity Allogeneic Stem Cell Transplantation.

Email alerts

ASH Publications

American Society of Hematology

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only